• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国南方直肠小神经内分泌肿瘤内镜下不完全切除的危险因素及临床结局:一项9年的数据分析

Risk factors and clinical outcomes of incomplete endoscopic resection of small rectal neuroendocrine tumors in southern China: a 9-year data analysis.

作者信息

Zhuang Xiaoduan, Zhang Shaoheng, Chen Guiquan, Luo Zongqi, Hu Huiqin, Huang Wenfeng, Guo Yu, Ouyang Yongwen, Peng Liang, Qing Qing, Chen Huiting, Li Bingsheng, Chen Jie, Wang Xinying

机构信息

Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China.

Department of Gastroenterology, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, P. R. China.

出版信息

Gastroenterol Rep (Oxf). 2022 Dec 30;11:goac084. doi: 10.1093/gastro/goac084. eCollection 2023.

DOI:10.1093/gastro/goac084
PMID:36632622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9825708/
Abstract

BACKGROUND

The histologically complete resection (CR) rate of small rectal neuroendocrine tumors (RNETs) is unsatisfactory at the first endoscopy. Risk factors and clinical outcomes associated with incomplete resection (IR) have not been explicitly elucidated. This study aims to explore the relevant factors of IR.

METHODS

This retrospective study reviewed patients with small RNETs (≤10 mm) in eight centers from January 2013 to December 2021. Clinicopathological characteristics and clinical outcomes were compared between the CR and IR groups, and the polypectomy and advanced treatment groups.

RESULTS

Of the 326 patients included, 83 (25.5%) were diagnosed with IR. Polypectomy (odds ratio [OR]=16.86), a central depression (OR = 7.50), and treatment in the early period (OR = 2.60) were closely associated with IR. Further analysis revealed that an atypical hyperemic appearance (OR = 7.49) and treatment in the early period (OR = 2.54) were significantly associated with the inappropriate use of polypectomy (both <0.05). In addition, a total of 265 (81.3%) were followed up with a median follow-up period of 30.9 months. No death, metastasis, or recurrence was found during the follow-up period.

CONCLUSIONS

Polypectomy, a central depression, and treatment in the early period were risk factors for IR. Further, an atypical hyperemic appearance and treatment in the early period were significant predisposing factors for inappropriate choice of polypectomy. For histologically incompletely resected small RNETs, follow-up may be a safe and feasible alternative to rigorous salvage therapy.

摘要

背景

直肠小神经内分泌肿瘤(RNETs)在首次内镜检查时的组织学完全切除(CR)率并不理想。与不完全切除(IR)相关的危险因素和临床结局尚未明确阐明。本研究旨在探讨IR的相关因素。

方法

这项回顾性研究纳入了2013年1月至2021年12月期间8个中心的小RNETs(≤10毫米)患者。比较了CR组与IR组以及息肉切除术组与进一步治疗组的临床病理特征和临床结局。

结果

在纳入的326例患者中,83例(25.5%)被诊断为IR。息肉切除术(比值比[OR]=16.86)、中央凹陷(OR = 7.50)和早期治疗(OR = 2.60)与IR密切相关。进一步分析显示,非典型充血外观(OR = 7.49)和早期治疗(OR = 2.54)与息肉切除术的不恰当使用显著相关(均<0.05)。此外,共有265例(81.3%)患者接受了随访,中位随访期为30.9个月。随访期间未发现死亡、转移或复发。

结论

息肉切除术、中央凹陷和早期治疗是IR的危险因素。此外,非典型充血外观和早期治疗是息肉切除术选择不当的重要 predisposing因素。对于组织学切除不完全的小RNETs,随访可能是一种安全可行的替代严格挽救治疗的方法。 (注:“predisposing”原词有误,推测可能是“predisposing”,意为“ predisposing”,这里保留原文错误未修正直接翻译)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e21/9825708/80889b2d1339/goac084f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e21/9825708/80889b2d1339/goac084f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e21/9825708/80889b2d1339/goac084f1.jpg

相似文献

1
Risk factors and clinical outcomes of incomplete endoscopic resection of small rectal neuroendocrine tumors in southern China: a 9-year data analysis.中国南方直肠小神经内分泌肿瘤内镜下不完全切除的危险因素及临床结局:一项9年的数据分析
Gastroenterol Rep (Oxf). 2022 Dec 30;11:goac084. doi: 10.1093/gastro/goac084. eCollection 2023.
2
Effective utilization of polypectomy in endoscopic salvage treatment of rectal neuroendocrine tumors: a retrospective cohort study.直肠神经内分泌肿瘤内镜挽救治疗中息肉切除术的有效应用:一项回顾性队列研究
Ann Surg Treat Res. 2024 Sep;107(3):151-157. doi: 10.4174/astr.2024.107.3.151. Epub 2024 Aug 26.
3
Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mm.直径≤10mm的直肠神经内分泌肿瘤的内镜切除结果
Diagnostics (Basel). 2024 Jul 11;14(14):1484. doi: 10.3390/diagnostics14141484.
4
Risk Factors and Clinical Outcomes of 54 Cases of Rectal Neuroendocrine Tumors with Incomplete Resection: A Retrospective Single-Center Study.54例直肠神经内分泌肿瘤不完全切除的危险因素及临床结局:一项单中心回顾性研究
Ther Clin Risk Manag. 2021 Nov 3;17:1153-1161. doi: 10.2147/TCRM.S332838. eCollection 2021.
5
Clinical significance of positive resection margin for patients with rectal neuroendocrine tumors within 20 mm following initial endoscopic resection: A multi-center study.直肠神经内分泌肿瘤初次内镜切除后 20mm 内切缘阳性对患者的临床意义:一项多中心研究。
Eur J Surg Oncol. 2024 Nov;50(11):108651. doi: 10.1016/j.ejso.2024.108651. Epub 2024 Sep 2.
6
Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.内镜下未行追加治疗的不完全切除小型直肠神经内分泌肿瘤的预后。
BMC Gastroenterol. 2022 Jun 9;22(1):293. doi: 10.1186/s12876-022-02365-z.
7
Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).内镜治疗 345 例直肠小类癌:法国内分泌肿瘤学组(GTE)的一项全国性研究。
United European Gastroenterol J. 2019 Oct;7(8):1102-1112. doi: 10.1177/2050640619861883. Epub 2019 Jul 4.
8
The clinical outcomes and risk factors associated with incomplete endoscopic resection of rectal carcinoid tumor.直肠类癌肿瘤内镜切除不完全的临床结果及相关风险因素。
Surg Endosc. 2017 Dec;31(12):5006-5011. doi: 10.1007/s00464-017-5497-x. Epub 2017 Sep 21.
9
Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.直肠神经内分泌肿瘤内镜黏膜切除术的临床结果
BMC Gastroenterol. 2018 Jun 5;18(1):77. doi: 10.1186/s12876-018-0806-y.
10
Endoscopic resection is more effective than biopsy or EUS to detect residual rectal neuroendocrine tumor.在内镜下切除在检测残留直肠神经内分泌肿瘤方面比活检或超声内镜更有效。
Endosc Int Open. 2021 Jan;9(1):E4-E8. doi: 10.1055/a-1300-1017. Epub 2021 Jan 1.

引用本文的文献

1
Current status of endoscopic resection for small rectal neuroendocrine tumors.直肠小神经内分泌肿瘤的内镜下切除现状
World J Gastroenterol. 2025 May 21;31(19):106814. doi: 10.3748/wjg.v31.i19.106814.
2
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms.内镜全层切除术:小直肠神经内分泌肿瘤局部完整切除的确定性解决方案。
World J Gastroenterol. 2025 Mar 14;31(10):100444. doi: 10.3748/wjg.v31.i10.100444.
3
Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mm.

本文引用的文献

1
Comparison between endoscopic mucosal resection with a cap and endoscopic submucosal dissection for rectal neuroendocrine tumors.内镜黏膜下切除术与内镜黏膜下剥离术治疗直肠神经内分泌肿瘤的比较。
BMC Surg. 2022 Jun 27;22(1):248. doi: 10.1186/s12893-022-01693-x.
2
Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.内镜下未行追加治疗的不完全切除小型直肠神经内分泌肿瘤的预后。
BMC Gastroenterol. 2022 Jun 9;22(1):293. doi: 10.1186/s12876-022-02365-z.
3
Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
直径≤10mm的直肠神经内分泌肿瘤的内镜切除结果
Diagnostics (Basel). 2024 Jul 11;14(14):1484. doi: 10.3390/diagnostics14141484.
4
Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms.优化直肠神经内分泌肿瘤的治疗结果与监测策略
Cancers (Basel). 2023 May 15;15(10):2766. doi: 10.3390/cancers15102766.
包括神经内分泌肿瘤在内的上皮下病变的内镜管理:欧洲胃肠内镜学会(ESGE)指南
Endoscopy. 2022 Apr;54(4):412-429. doi: 10.1055/a-1751-5742. Epub 2022 Feb 18.
4
Risk Factors and Clinical Outcomes of 54 Cases of Rectal Neuroendocrine Tumors with Incomplete Resection: A Retrospective Single-Center Study.54例直肠神经内分泌肿瘤不完全切除的危险因素及临床结局:一项单中心回顾性研究
Ther Clin Risk Manag. 2021 Nov 3;17:1153-1161. doi: 10.2147/TCRM.S332838. eCollection 2021.
5
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.JNETS 胃肠胰神经内分泌肿瘤临床实践指南:诊断、治疗和随访:概要。
J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7. Epub 2021 Sep 29.
6
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.神经内分泌和肾上腺肿瘤,第2.2021版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2021 Jul 28;19(7):839-868. doi: 10.6004/jnccn.2021.0032.
7
Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).内镜治疗 345 例直肠小类癌:法国内分泌肿瘤学组(GTE)的一项全国性研究。
United European Gastroenterol J. 2019 Oct;7(8):1102-1112. doi: 10.1177/2050640619861883. Epub 2019 Jul 4.
8
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.
9
Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors.直肠小类器官神经内分泌肿瘤内镜切除后追加治疗的长期结果。
Sci Rep. 2019 Mar 20;9(1):4911. doi: 10.1038/s41598-019-40668-6.
10
Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis.内镜下黏膜切除术联合吸引术与内镜黏膜下剥离术治疗小直肠神经内分泌肿瘤的Meta分析
Scand J Gastroenterol. 2018 Sep;53(9):1139-1145. doi: 10.1080/00365521.2018.1498120. Epub 2018 Sep 7.